Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

CTI launches cancer drug Pixuvri in UK

Now available to treat form of non-Hodgkin lymphoma

Chugai appoints US CMO

Athos Gianella-Borradori has clinical experience at Novartis and Merck Serono

- PMLiVE

Schmittgall wins Omega contract

German agency will lead promotion of several key products

- PMLiVE

Following the biologic path

Biosimilar regulations in Canada, the US and Europe all have a degree of uncertainty

Pegasus Moves to Brighton

Top UK Healthcare Communications Consultancy Moves to Brighton

Inizio

Sanofi reception

Sanofi won’t take part in mega-deal trend

CEO says French firm will stick to bolt-on acquisitions

- PMLiVE

Forest Labs agrees $1.46bn deal to buy Furiex

Gains access to promising IBS drug eluxadoline

- PMLiVE

GSK’s COPD drug Incruse cleared in Europe

Medicine is GSK’s first long-acting muscarinic antagonist

EU flag

J&J wins EU approval for diabetes combo

Vokanamet combines Invokana and metformin

- PMLiVE

Lonza appoints pharma COO

Marc Funk replaces Stephan Kutzer

- PMLiVE

New Novartis MS app will turn up the heat on its rivals

Patients can use SymTrac iPhone app to track symptoms and relapses on their current treatment

The price of admission

The commoditisation of healthcare is a flawed proposition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links